Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1509745 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.61Day −2.03%Mkt cap $65MP/E (FY) 8.8×Off 52W high −83.4%Vol (1Y) 179.6%
Daily closing price, split-adjusted to the current basis; 0.7y shown of 165 bars on file. Sampled to 165 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest7.6% of sh out |
| Days to cover3.8d |
| 13F net flow (QoQ)−1.84% |
| Top-10 13F concentration90.1% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)8.8× |
| Sales (TTM)$1.5M |
| Earnings (TTM)-$56.9M |
| ROE5.1% |
| ROIC−30.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−47.1% |
Total return through 2026-07-28 · series begins 2025-11-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)179.6% |
| Ann. volatility (3Y)179.6% |
| Sharpe (1Y)−0.04 |
| Sharpe (3Y)−0.04 |
| Max drawdown (1Y)−82.7% |
| Max drawdown (3Y)−82.7% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 2.3M | $2M | 2.20% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $1M | 1.71% | new |
| RENAISSANCE TECHNOLOGIES LLC | 725,120 | $576,180 | 0.68% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 571,068 | $453,922 | 0.54% | +7.7% |
| VANGUARD FIDUCIARY TRUST CO | 297,086 | $236,183 | 0.28% | new |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 262,953 | $208,942 | 0.25% | −52.8% |
| UBS Group AG | 171,068 | $135,999 | 0.16% | +449.3% |
| Cygnus Capital Advisors, LLC | 11,492 | $135,000 | 0.01% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.46 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.08 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.40 | — | — | — |
| 2025-03-31 | 2025-05-13 | −$0.37 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
